Biolase, Inc.
BIOL
BIOL was delisted on the 18th of June, 2024.
38 hedge funds and large institutions have $14.4M invested in Biolase, Inc. in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 5 closing their positions.
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
23% more funds holding
Funds holding: 31 → 38 (+7)
17% more capital invested
Capital invested by funds: $12.4M → $14.4M (+$2.06M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.01M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$820K |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$522K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$491K |
| 5 |
Two Sigma Advisers
New York
|
+$219K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$96.3K |
| 2 |
State Street
Boston,
Massachusetts
|
-$80K |
| 3 |
AG
Algert Global
San Francisco,
California
|
-$13K |
| 4 |
LFG
Larson Financial Group
St Louis,
Missouri
|
-$13K |
| 5 |
Renaissance Technologies
New York
|
-$11.4K |
BIOL Hedge Fund Activity: Q3 2021 in Review
38 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q3 2021, worth a combined $14.4M — up 17% from $12.4M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new BIOL positions and 5 closed out — a net gain of 7 holders — while 9 added to existing stakes and 5 trimmed.
The largest buyer was Millennium Management, adding an estimated $1.01M. The largest seller was Goldman Sachs, cutting an estimated $96.3K.
- 38 institutional investors held Biolase, Inc. (BIOL) as of Q3 2021, up from 31 in Q2 2021.
- Funds reported $14.4M of Biolase, Inc. stock for Q3 2021, up 17% quarter-over-quarter.
- 12 funds opened new Biolase, Inc. positions in Q3 2021 and 5 closed out, a net change of +7 holders.
- The largest Biolase, Inc. buyer in Q3 2021 was Millennium Management, an estimated $1.01M added.
- The largest Biolase, Inc. seller in Q3 2021 was Goldman Sachs, an estimated $96.3K sold.
Based on aggregated 13F filings for Q3 2021.